Members of the HSP90 family play an imperative role in regulating the subtle equilibrium between glycolytic metabolism and OXPHOS, in response to the changes in the tumor microenvironment, such as nutrient and oxygen deprivation and exposure to toxic agents, triggering cell transformation and tumor progression [63,64,65]. The gene discussed is HSP90AA1; the disease is neoplasm.